Literature DB >> 19806335

Exposure of treating physician to radiation during prostate brachytherapy using iodine-125 seeds: dose measurements on both hands with thermoluminescence dosimeters.

Hans Schiefer1, Friedrich von Toggenburg, Wolf Seelentag, Ludwig Plasswilm, Gerhard Ries, Cornelius Lenggenhager, Hans-Peter Schmid, Thomas Leippold, Ladislav Prikler, Bernd Krusche, Jakob Roth, Daniel Engeler.   

Abstract

BACKGROUND AND
PURPOSE: Only sparse reports have been made about radiation exposure of the treating physician during prostate seed implantation. Therefore, thermoluminescence dosimeter (TLD) measurements on the index fingers and the backs of both hands were conducted.
MATERIAL AND METHODS: Stranded iodine-125 seeds with a mean apparent activity of 27.4 MBq per seed were used. During application, the treating physician manipulated the loaded needle with the index fingers, partially under fluoroscopic control. Four physicians with varying experience treated 24 patients. The radiation exposure was determined with TLD-100 chips attached to the index fingertips and the backs of hands. Radiation exposure was correlated with the physician's experience.
RESULTS: The average brachytherapy duration by the most experienced physician was 19.2 min (standard deviation sigma = 1.2 min; novices: 34.8 min [sigma = 10.2 min]). The mean activity was 1,703 MBq (sigma = 123 MBq), applied with 16.3 needles (sigma = 2.5 needles; novices: 1,469 MBq [sigma = 229 MBq]; 16.8 needles [sigma = 2.3 needles]). The exposure of the finger of the "active hand" and the back of the hand amounted to 1.31 mSv (sigma = 0.54 mSv) and 0.61 mSv (sigma = 0.23 mSv), respectively (novices: 2.07 mSv [sigma = 0.86 mSv] and 1.05 mSv [sigma = 0.53 mSv]).
CONCLUSION: If no other radiation exposure needs to be considered, an experienced physician can perform about 400 applications per year without exceeding the limit of 500 mSv/year; for novices, the corresponding figure is about 200.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19806335     DOI: 10.1007/s00066-009-1990-z

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  22 in total

1.  [Physical and technical quality assurance and radiation protection in transperineal interstitial permanent prostate brachytherapy with 125-iodine seeds].

Authors:  Theodor W Kaulich; Ulf Lamprecht; Frank Paulsen; Joachim Lorenz; Uwe Maurer; Wolfgang Loeser; Karl-Horst Bichler; Fridtjof Nüsslin; Michael Bamberg
Journal:  Strahlenther Onkol       Date:  2002-12       Impact factor: 3.621

2.  Radiation exposure to operating room personnel during transperineal interstitial permanent prostate brachytherapy.

Authors:  David J Schwartz; Brian J Davis; Richard J Vetter; Thomas M Pisansky; Michael G Herman; Torrence M Wilson; Wayne N LaJoie; Ann L Oberg
Journal:  Brachytherapy       Date:  2003       Impact factor: 2.362

3.  [Determination of organ doses and effective doses in radiooncology].

Authors:  Jakob Roth; Aurélien Emmanuel Martinez
Journal:  Strahlenther Onkol       Date:  2007-07       Impact factor: 3.621

4.  Guideline for the management of clinically localized prostate cancer: 2007 update.

Authors:  Ian Thompson; James Brantley Thrasher; Gunnar Aus; Arthur L Burnett; Edith D Canby-Hagino; Michael S Cookson; Anthony V D'Amico; Roger R Dmochowski; David T Eton; Jeffrey D Forman; S Larry Goldenberg; Javier Hernandez; Celestia S Higano; Stephen R Kraus; Judd W Moul; Catherine M Tangen
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

5.  An overview of the use of extremity dosemeters in some European countries for medical applications.

Authors:  L Donadille; E Carinou; M Ginjaume; J Jankowski; A Rimpler; M Sans Merce; F Vanhavere
Journal:  Radiat Prot Dosimetry       Date:  2008-08-23       Impact factor: 0.972

6.  [Improvement of the radiological protection in the interstitial radiotherapy with radiogold seeds (author's transl)].

Authors:  J Schmidt
Journal:  Strahlentherapie       Date:  1981-01

7.  Assessment with TLD of radiation exposure to staff during radium insertions in cancer of cervix.

Authors:  M P Jain; A Nagaratnam; D Ghosh
Journal:  Br J Radiol       Date:  1980-11       Impact factor: 3.039

8.  An in vivo investigative protocol for HDR prostate brachytherapy using urethral and rectal thermoluminescence dosimetry.

Authors:  Warren Toye; Ram Das; Tomas Kron; Rick Franich; Peter Johnston; Gillian Duchesne
Journal:  Radiother Oncol       Date:  2008-10-25       Impact factor: 6.280

9.  Seed displacements after permanent brachytherapy for prostate cancer in dependence on the prostate level.

Authors:  Michael Pinkawa; Bernd Gagel; Branka Asadpour; Marc D Piroth; Jens Klotz; Holger Borchers; Gerhard Jakse; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2008-10-01       Impact factor: 3.621

10.  Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer.

Authors:  Pirus Ghadjar; Oscar Matzinger; Bernhard Isaak; Frank Behrensmeier; Andrea Stroux; Cyrill A Rentsch; George N Thalmann; Daniel M Aebersold
Journal:  Radiother Oncol       Date:  2009-01-21       Impact factor: 6.280

View more
  4 in total

1.  Impact of learning curve and technical changes on dosimetry in low-dose brachytherapy for prostate cancer.

Authors:  E Le Fur; J P Malhaire; D Baverez; F Delage; M A Perrouin-Verbe; F Schlurmann; S Guerif; G Fournier; O Pradier; A Valeri
Journal:  Strahlenther Onkol       Date:  2012-11-11       Impact factor: 3.621

2.  Collection and evaluation of incidents in a radiotherapy department : a reactive risk analysis.

Authors:  Maurizio Portaluri; Fulvio Italo Maria Fucilli; Emilio Antonio Luca Gianicolo; Francesco Tramacere; Maria Carmen Francavilla; Cristina De Tommaso; Roberta Castagna; Giorgio Pili
Journal:  Strahlenther Onkol       Date:  2010-11-30       Impact factor: 3.621

3.  Radiation protection of persons living close to patients with radioactive implants.

Authors:  Theodor W Kaulich; Michael Bamberg
Journal:  Strahlenther Onkol       Date:  2010-01-28       Impact factor: 3.621

4.  A novel perineal shield for low-dose-rate prostate brachytherapy.

Authors:  Joseph P Weiner; David Schwartz; Joseph Safdieh; Alex Polubarov; Tejas Telivala; Matthew Worth; David Schreiber
Journal:  J Contemp Brachytherapy       Date:  2015-06-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.